Johnson & Johnson

US

JNJ

Health Care

149.12 ₽

Current price

Sell
149.12 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    878 / 1328

  • Position in country

    9359 / 14179

  • Return on Assets, %

    7.4

    -2.7

  • Net income margin, %

    19.3

    2.8

  • EBITDA margin, %

    31.1

    10.8

  • Debt to Equity, %

    42.6

    19.2

  • Intangible assets and goodwill, %

    42.2

    3.6

  • Revenue CAGR 3Y, %

    1

    8.5

  • Total Equity change 1Y, %

    -10.5

    0

  • Revenue Y, % chg

    6.4

    0.5

  • P/E

    27.9

    22.7

  • P/BV

    5.1

    1.5

  • P/S

    4.1

    2.3

  • EV/S

    4.2

    2.4

  • EV/EBITDA

    11.7

    7.4

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    18.6

    51.3

  • Forward P/E

    13.7

    15.6

  • Dividend Yield, %

    3.2

    1.7

  • Forward Dividend Yield, %

    3.3

    0.2

  • Expected dividend per share

    4.9

    0

  • Payout Ratio, %

    88.3

    30.3

  • Dividend Ex Date

    2024-02-16

Get an analytical review of this company

Competitors

Ranks

  • Royalty Pharma PLC

    00%

  • Zoetis Inc

    00%

  • Eli Lilly and Co

    00%

  • Bristol-Myers Squibb Co

    00%

  • Elanco Animal Health Inc

    00%

  • Johnson & Johnson

    00%

  • Viatris Inc

    00%

  • Merck & Co Inc

    00%

  • Pfizer Inc

    00%

  • Catalent Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    355491.1

  • Ticker

    JNJ.N

  • ISIN

    US4781601046

  • IPO date

    1944-09-25

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-16

  • Date fact. publication of reports

    2023-12-31

Company Description

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.